サインイン 無料でサインアップします。

Last updated: 11 July 2024 at 5:30pm EST

John Henneman Net Worth




The estimated Net Worth of John B Iii Henneman is at least 6.58 百万$ dollars as of 13 March 2024. Mr. Henneman owns over 6,860 units of Aprea Therapeutics stock worth over 26,208$ and over the last 22 years he sold APRE stock worth over 6,355,301$. In addition, he makes 201,489$ as Lead Independent Director at Aprea Therapeutics.

Mr. Henneman APRE stock SEC Form 4 insiders trading

John has made over 58 trades of the Aprea Therapeutics stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 6,860 units of APRE stock worth 50,009$ on 13 March 2024.

The largest trade he's ever made was exercising 100,000 units of Aprea Therapeutics stock on 2 November 2010 worth over 3,025,000$. On average, John trades about 5,894 units every 57 days since 2003. As of 13 March 2024 he still owns at least 8,139 units of Aprea Therapeutics stock.

You can see the complete history of Mr. Henneman stock trades at the bottom of the page.





John Henneman biography

John Bell Henneman III serves as Lead Independent Director of the Company. Mr. Henneman has more than 25 years of combined financial and operational management experience in the life sciences industry. From July 2018 until November 2018, Mr. Henneman served as the Chief Administrative Officer of NewLink Genetics Corporation, a biotechnology company. From October 2014 to July 2018, Mr. Henneman served as Executive Vice President and Chief Financial Officer at NewLink Genetics Corporation, a biopharmaceutical company. From 1998 to 2014, Mr. Henneman served at Integra LifeSciences Holdings Corp (“Integra”)., a publicly-held medical device company, in various capacities. Before becoming Integra’s Chief Financial Officer in 2007, Mr. Henneman was Chief Administrative Officer, responsible for Integra’s regulatory affairs, quality systems, clinical affairs, human resources, information systems and legal affairs functions, the management of Integra’s surgical instruments business, and Integra’s business development function. Mr. Henneman currently serves on the boards of directors of R1 RCM, Inc., a publicly-held revenue cycle technology and management services company, SeaSpine Holdings Corporation, a publicly-held medical technology company, and Alafair Biosciences, Inc., a privately-held medical device company. Mr. Henneman is also senior advisor to Prettybrook Partners, a private equity firm, and a consultant to SparkMed Advisors LLC, which provides consulting and other services to start-up medical device and biotechnology companies.

What is the salary of John Henneman?

As the Lead Independent Director of Aprea Therapeutics, the total compensation of John Henneman at Aprea Therapeutics is 201,489$. There are 6 executives at Aprea Therapeutics getting paid more, with Christian Schade having the highest compensation of 3,677,570$.



How old is John Henneman?

John Henneman is 58, he's been the Lead Independent Director of Aprea Therapeutics since 2020. There are 9 older and 8 younger executives at Aprea Therapeutics. The oldest executive at Aprea Therapeutics, Inc. is Guido Magni, 67, who is the Independent Director.

Insiders trading at Aprea Therapeutics

Over the last 5 years, insiders at Aprea Therapeutics have traded over 63,126,246$ worth of Aprea Therapeutics stock and bought 2,073,560 units worth 29,606,912$ . The most active insiders traders include Group, Llc Green Jeremy Red...、Vantage I, L.P.Versant Vant...、John B Iii Henneman. On average, Aprea Therapeutics executives and independent directors trade stock every 43 days with the average trade being worth of 420,918$. The most recent stock trade was executed by John P. Hamill on 13 March 2024, trading 1,010 units of APRE stock currently worth 7,363$.



What does Aprea Therapeutics do?

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.



What does Aprea Therapeutics's logo look like?

Aprea Therapeutics, Inc. logo

Complete history of Mr. Henneman stock trades at Anika Therapeutics、Integra Lifesciences Corp、Orthofix Medical Inc、R1 RCM、SeaSpine Corp、Aprea Therapeutics

日付
#
会社
 インサイダー
取引
取引
 株式 1株当たりの株価 合計金額 その後の株式数 ソース
13 Mar 2024 APRE Aprea Therapeutics, Inc. John B Iii Henneman
ディレクター
 購入する 6,860 7.29$ 50,009$
13 Mar 2024
8,139 ↗
7 Oct 2019 APRE Aprea Therapeutics, Inc. John B Iii Henneman
ディレクター
 購入する 5,000 15.00$ 75,000$
7 Oct 2019
5,000 ↗
8 Aug 2023 RCM R1 RCM Inc. John B Iii Henneman
ディレクター
 オプション行使 50,000 2.61$ 130,500$
8 Aug 2023
122,114 ↗
21 May 2022 RCM R1 RCM Inc. John B Iii Henneman
ディレクター
 オプション行使 5,151 21.66$ 111,571$
21 May 2022
54,751 ↗
18 May 2021 ANIK Anika Therapeutics Inc. John B Iii Henneman
ディレクター
 購入する 2,000 42.86$ 85,720$
18 May 2021
11,310 ↗
5 Aug 2020 SPNE SeaSpine Holdings Corp John B Iii Henneman
ディレクター
 販売 10,000 15.00$ 150,000$
5 Aug 2020
60,458 ↗
27 Aug 2018 SPNE SeaSpine Holdings Corp John B Iii Henneman
ディレクター
 販売 10,000 14.68$ 146,800$
27 Aug 2018
54,708 ↗
13 Jun 2018 SPNE SeaSpine Holdings Corp John B Iii Henneman
ディレクター
 オプション行使 17,398 12.44$ 216,431$
13 Jun 2018
64,708 ↗
25 Aug 2014 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 20,000 50.12$ 1,002,400$
25 Aug 2014
34,159 ↗
10 Mar 2014 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 10,000 49.00$ 490,000$
10 Mar 2014
53,611 ↗
27 Feb 2014 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 5,000 46.07$ 230,350$
27 Feb 2014
63,611 ↗
19 Aug 2013 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 30,000 42.08$ 1,262,400$
19 Aug 2013
72,669 ↗
10 Aug 2012 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 3,000 39.40$ 118,200$
10 Aug 2012
64,542 ↗
26 Apr 2012 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 5,000 37.20$ 186,000$
26 Apr 2012
67,542 ↗
3 May 2011 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 3,855 51.73$ 199,419$
3 May 2011
68,294 ↗
8 Mar 2011 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 10,000 49.38$ 493,800$
8 Mar 2011
110,656 ↗
7 Dec 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 5,324 47.46$ 252,677$
7 Dec 2010
84,424 ↗
2 Nov 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 100,000 30.25$ 3,025,000$
2 Nov 2010
119,139 ↗
16 Apr 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 7,500 38.72$ 290,400$
16 Apr 2010
97,248 ↗
15 Mar 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 16,200 35.52$ 575,424$
15 Mar 2010
105,948 ↗
8 Mar 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 8,800 35.52$ 312,576$
8 Mar 2010
101,113 ↗
15 Jan 2010 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 20,000 32.32$ 646,400$
15 Jan 2010
112,313 ↗
15 Dec 2009 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 3,000 35.26$ 105,780$
15 Dec 2009
85,941 ↗
16 Nov 2009 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 25,000 28.78$ 719,500$
16 Nov 2009
95,641 ↗
26 Aug 2009 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 5,500 34.83$ 191,565$
26 Aug 2009
88,941 ↗
3 Apr 2009 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 20,000 22.78$ 455,600$
3 Apr 2009
106,628 ↗
16 Dec 2008 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 20,000 18.63$ 372,600$
16 Dec 2008
52,078 ↗
14 Nov 2008 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 21,056 17.66$ 371,849$
14 Nov 2008
33,078 ↗
11 Nov 2008 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,006 17.67$ 70,786$
11 Nov 2008
32,078 ↗
13 Jun 2008 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 10,000 14.87$ 148,700$
13 Jun 2008
38,072 ↗
5 Dec 2007 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 38,000 26.56$ 1,009,280$
5 Dec 2007
51,572 ↗
1 Jun 2007 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 38,000 26.70$ 1,014,600$
1 Jun 2007
60,072 ↗
14 May 2007 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 38,000 26.70$ 1,014,600$
14 May 2007
27,694 ↗
12 Mar 2007 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 37,088 26.92$ 998,409$
12 Mar 2007
59,660 ↗
23 Feb 2007 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 912 27.78$ 25,335$
23 Feb 2007
23,484 ↗
15 Nov 2006 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
販売 37,547 40.64$ 1,525,910$
15 Nov 2006
22,572 ↗
15 Mar 2006 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 1,929 13.63$ 26,292$
15 Mar 2006
42,048 ↗
6 Jan 2006 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 5,000 6.56$ 32,800$
6 Jan 2006
39,423 ↗
15 Dec 2005 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 18,417 5.88$ 108,292$
15 Dec 2005
56,485 ↗
28 Nov 2005 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,143 5.88$ 36,121$
28 Nov 2005
38,068 ↗
1 Jun 2005 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 10,000 5.50$ 55,000$
1 Jun 2005
41,925 ↗
14 Mar 2005 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 625 3.50$ 2,188$
14 Mar 2005
31,925 ↗
1 Feb 2005 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,605 3.50$ 16,118$
1 Feb 2005
35,905 ↗
9 Aug 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 15,325 4.38$ 67,124$
9 Aug 2004
0 ↗
12 Jul 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
12 Jul 2004
30,428 ↗
14 Jun 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
14 Jun 2004
0 ↗
10 May 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
10 May 2004
0 ↗
12 Apr 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
12 Apr 2004
0 ↗
8 Mar 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
8 Mar 2004
0 ↗
9 Feb 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
9 Feb 2004
0 ↗
19 Jan 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 5,324 3.38$ 17,995$
19 Jan 2004
30,428 ↗
12 Jan 2004 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 6,000 4.38$ 26,280$
12 Jan 2004
0 ↗
8 Dec 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,000 4.38$ 17,520$
8 Dec 2003
0 ↗
10 Nov 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,000 4.38$ 17,520$
10 Nov 2003
0 ↗
13 Oct 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,000 4.38$ 17,520$
13 Oct 2003
0 ↗
8 Sep 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,000 4.38$ 17,520$
8 Sep 2003
0 ↗
11 Aug 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 4,000 4.38$ 17,520$
11 Aug 2003
0 ↗
31 Jul 2003 IART Integra Lifesciences Holdings Corp John B Iii Henneman
Exec. V.P.、CAO、参事
オプション行使 5,321 4.38$ 23,306$
31 Jul 2003
23,688 ↗


Aprea Therapeutics executives and stock owners

Aprea Therapeutics executives and other stock owners filed with the SEC include: